BioMarin Pharmaceutical | BMRN - Capitale Sociale E Riserve

Prezzo Delle Azioni
56.50
Cambio Giornaliero
-0.70 -1.22%
Mensile
-7.21%
Annuale
0.32%
Q2 Previsione
53.83




Capitale Sociale E Riserve Cambiamento Data
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amgen USD 8.66B 961M 2025-12
Bayer EUR 25.95B 3.75B 2025-12
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
Incyte USD 5.17B 516.28M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Moderna USD 8.65B 680M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 71.71B 14.25B 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
United Therapeutics USD 7.1B 506M 2025-12
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12